Frontiers in Pharmacology · 2021 · 15 citations · 47 references
MedicinePharmacologyPhysiologyCellular PharmacologyDiabetologyInflammationCardiovascular Molecular PhysiologyDiabetes MellitusDiabetes PharmacotherapyEndothelial DysfunctionInsulin ResistanceAortic BiomechanicsArterial StiffnessBlood PressureDiabetes-associated Vascular ChangesDiabetes-related ComplicationsMacrovascular ComplicationsTissue StiffeningVascular Stiffness
Background and Purpose: Macrovascular complication of diabetes mellitus, characterized by increased aortic stiffness, is a major cause leading to many adverse clinical outcomes. It has been reported that ginsenoside Rb1 (Rb1) can improve glucose tolerance, enhance insulin activity, and restore the impaired endothelial functions in animal models. The aim of this study was to explore whether Rb1 could alleviate the pathophysiological process of arterial stiffening in diabetes and its potential mechanisms. Experimental Approach: Diabetes was induced in male C57BL/6 mice by administration of streptozotocin. These mice were randomly selected for treatment with Rb1 (10−60 mg/kg, i. p.) once daily for 8 weeks. Aortic stiffness was assessed using ultrasound and measurement of blood pressure and relaxant responses in the aortic rings. Mechanisms of Rb1 treatment were studied in MOVAS-1 VSMCs cultured in a high-glucose medium. Key Results: Rb1 improved DM-induced arterial stiffening and the impaired aortic compliance and endothelium-dependent vasodilation. Rb1 ameliorated DM-induced aortic remodeling characterized by collagen deposition and elastic fibers disorder. MMP2, MMP9, and TGFβ1/Smad2/3 pathways were involved in this process. In addition, Rb1-mediated improvement of arterial stiffness was partly achieved via inhibiting oxidative stress in DM mice, involving regulating NADPH oxidase. Finally, Rb1 could blunt the inhibition effects of DM on AMPK phosphorylation. Conclusion and Implications: Rb1 may represent a novel prevention strategy to alleviate collagen deposition and degradation to prevent diabetic macroangiopathy and diabetes-related complications.
47
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
Rury R. Holman, Sanjoy K. Paul, M. Angelyn Bethel et al. · New England Journal of Medicine · 2008 · 7.8K citations · Full text
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
Sophia Zoungas, John Chalmers, Bruce Neal et al. · New England Journal of Medicine · 2014 · 624 citations · Full text
Yasmin Yasmin, Sharon Wallace, Carmel M. McEniery et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2004 · 498 citations · Full text
Medicine, Cardiology, Physiology +14
Cross-Sectional Correlates of Increased Aortic Stiffness in the Community
Gary F. Mitchell, Chao‐Yu Guo, Emelia J. Benjamin et al. · Circulation · 2007 · 264 citations · Full text